# FDA WARNING_LETTER - Jiangsu Hengrui Pharmaceuticals Co., Ltd. - January 16, 2024

Source: https://www.globalkeysolutions.net/records/warning_letter/jiangsu-hengrui-pharmaceuticals-co-ltd/be00abd9-bc76-4c95-8a7e-7057a5d1b6eb

> FDA WARNING_LETTER for Jiangsu Hengrui Pharmaceuticals Co., Ltd. on January 16, 2024. Product: Drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: WARNING_LETTER
- Company Name: Jiangsu Hengrui Pharmaceuticals Co., Ltd.
- Inspection Date: 2024-01-16
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [CRL - Unknown Date](https://www.globalkeysolutions.net/records/crl/jiangsu-hengrui-pharmaceuticals-co-ltd/29f111a1-3244-464e-b5ef-aa4072cb22ce)
- [CRL - Unknown Date](https://www.globalkeysolutions.net/records/crl/jiangsu-hengrui-pharmaceuticals-co-ltd/02258f6e-3f99-44b5-812d-00e05e5ea11a)

## Related Officers

- [Director](https://www.globalkeysolutions.net/people/francis-godwin/1556d203-d47c-4744-af37-2591a163149e)
- [Compliance Officer / Investigator](https://www.globalkeysolutions.net/people/erika-v-butler/3e654530-4c29-403d-880e-a5422315c3c0)

Company: https://www.globalkeysolutions.net/companies/jiangsu-hengrui-pharmaceuticals-co-ltd/d8430568-25ba-4cb0-a549-75fa7caf0a45

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
